Automated Analysis With BD Elastigate™ Aboard The BD FACSLyric™ Cell Analyzer

Sahul shares a decade-long journey in advancing cytometry for cell therapy, starting from the early days of limited guidance and trial-and-error workflows. He highlights the challenges of standardization across global sites, variability in instrumentation, and the need for robust GMP processes. Key innovations include lyophilized antibodies for improved reagent stability, automated gating through machine learning, and tools like the BD Elastigate™ that deliver precision equivalent to expert analysts, even with minimal training files. These advancements have streamlined workflows, ensured consistency across 30+ instruments worldwide, and supported compliance with evolving regulatory expectations.

Explore how collaboration and technology transformed cytometry from a fragmented process into a scalable, standardized solution for modern cell therapy.